BioScale’s AMMP™ (Acoustic Membrane and Microparticle) technology platform is a quantitative, ultra-sensitive system for life sciences and diagnostics applications. While BioScale’s current product portfolio includes primarily protein research tools, the performance of AMMP technology has been demonstrated across a wide variety of analytes including mammalian cells, antibodies, bacteria, viruses, proteins, hormones, DNA, virus, aptamers and small molecules. The platform can accommodate samples from a variety of matrices — cell culture soups, whole blood, serum, plasma, urine, food, and stool. AMMP technology enables scientists and clinicians to evaluate fundamental questions at biologically relevant levels in a simple, flexible, and user-friendly format.
We are continuing to expand AMMP’s unique capabilities to deliver customer-focused solutions. Representative data exhibiting picogram-level detection in complex matrices using AMMP technology for applications other than protein analysis is available. We are currently exploring alliances and partnerships focused on AMMP Technology from product co-development to joint ventures. Learn more about BioScale partnership opportunities using AMMP technology.
| Samples | Analytes |
| Cell Cultures | Proteins |
| Whole Blood | Hormones |
| Serum | DNA |
| Plasma | Whole Cells |
| Urine | Bacteria |
| Stool | Viruses |
| Food | Small Molecule |



